Jourdi, Georges

Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban. [electronic resource] - Thrombosis and haemostasis Jul 2015 - 78-86 p. digital

Publication Type: Comparative Study; Journal Article

2567-689X

10.1160/TH14-10-0877 doi


Blood Coagulation--drug effects
Computer Simulation
Factor Xa Inhibitors--pharmacology
Half-Life
Humans
Hydrogen-Ion Concentration
Kinetics
Models, Biological
Prothrombin Time
Pyrazoles--pharmacology
Pyridones--pharmacology
Rivaroxaban--pharmacology
Thrombin--metabolism